Home Tags CanSinoBIO

Tag: CanSinoBIO

COVID Watch

COVID Watch | 9th February 2021

0
CanSinoBIO Phase III clinical trials in Pakistan record an efficacy of 74.8% in protecting against COVID-19 symptoms and 100% protection against developing severe complications. WHO, DRAP and EPI conduct workshop on monitoring 'adverse events' following COVID-19 immunization. Sindh to purchase 20 million vaccine doses from China.
COVID Watch

COVID Watch | 29th January 2021

0
Research for CanSinoBIO vaccine has now entered the follow-up stage for which it has entered an agreement with the PITB to keep in contact with 18,000 volunteers. Punjab Chief Minister Usman Buzdar approves Rs. 50 million to purchase gene-sequencing technology. Punjab Health Minister Yasmin Rashid announces that Punjab has completed its COVAX trials.
COVID Watch

COVID Watch | 22nd January 2021

0
China to gift Pakistan 500,000 vials of Sinopharm vaccine as goodwill gesture by end of January, reveals Foreign Minister Shah Mehmood Qureshi; Punjab Secondary Education Department carries out regular randomized testing in schools ahead of meeting to decide reopening primary and middle schools; Sputnik-V approaches DRAP for registration of vaccine which boasts 73 to 85 percent efficacy
COVID Watch

COVID Watch | 21st December 2020

0
CanSinoBIO vaccine candidate expected to begin registration as just 20% of volunteer pool remains, clinical trials of an Australian vaccine may begin in January of next year. For more updates on the second wave, keep scrolling.